Vigilant Diagnostics LLC

Medtech · Private

Portable thermal contrast reader for detecting gold nanoparticles in influenza lateral flow assays

Claim this profile

Follows are private to you and power your alerts

Updated

Sector
Medtech
Total capital
$602K
Federal grants
$602K
2 awards · 2017
Rank in peer group#9 of 542
Private capital raised
None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts
None on recordNo federal contract awards found.
Granted patents
0
6 pending

Capital timeline

2017FEDERAL ↑EQUITY ↓Cumulative $602K$301K$301K
2017FEDERAL ↑EQUITY ↓Cumulative $602K$301K$301K

Latest events

  • Federal grantHealth and Human S · Phase I · Vastly improved influenza diagnostics through the development of a handheld thermal contrast reader$301K
  • Federal grantHealth and Human S · Phase I · Vastly improved influenza diagnostics through the development of a handheld thermal contrast reader$301K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 542 peers

Line = median

Medtech · Device

  • Federal grants#9 · top 2%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 0 granted of 6
  • PendingLED thermal contrast assay and readerUSPTOApplication 18872114
  • PendingLed Thermal Contrast Assay And ReaderUSPTOApplication 63349380
  • PendingDesigns And Methods For The Readout Of Thermal Contrast Amplification SignalsUSPTOApplication PCTUS2024058425
Show all 6 patent records
  • LED thermal contrast assay and readerOct 23, 2025 · Application 18872114Pending
  • Led Thermal Contrast Assay And ReaderApplication 63349380Pending
  • Designs And Methods For The Readout Of Thermal Contrast Amplification SignalsApplication PCTUS2024058425Pending
  • Designs And Methods For The Readout Of Thermal Contrast Amplification SignalsApplication 63606288Pending
  • Led Thermal Contrast Assay And ReaderApplication PCTUS2023024586Pending
  • Designs and methods for the readout of thermal contrast amplification signalsApplication 19592431Pending
  • IMMUNOWORK, LLCSimilar federal contract value in Medtech · null in contracts
  • GENNEXT TECHNOLOGIES, INC.Similar federal contract value in Medtech · null in contracts
  • ALERJE, INC.Similar federal contract value in Medtech · null in contracts
  • ZYMERON CORPORATIONSimilar federal contract value in Medtech · null in contracts
  • Farapulse, Inc.Similar federal contract value in Medtech · null in contracts
  • SphereVis LLCSimilar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .